Sources:
American Academy of Physical Medicine and Rehabilitation: “PASC Dashboard.”
Jana Fridley, MD, executive director, Post-COVID Rehabilitation and Recovery Clinic, University of Washington.
National Institutes of Health: “Coronavirus Disease 2019 (COVID-19) Treatment Guidelines,” “RECOVER: Researching COVID,” “RECOVER Program Takes First Steps in Progressing Toward Clinical Trials to Better Understand Long COVID.”
cancer: “Prevalence and Characteristics of Moderate and Severe Fatigue: A Multicenter Study in Cancer Patients and Survivors.”
National Institute for Health and Care Excellence: “Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (or Encephalopathy): Diagnosis and Management.”
Monica Verduzco Gutierrez, MD, chief of rehabilitation medicine, director of the COVID-19 Recovery Clinic, University of Texas Health Science Center at San Antonio.
PM&R: “An Interdisciplinary Collaborative Consensus Guiding Statement on the Evaluation and Treatment of Fatigue in Post-Acute Consequences of Patients with SARS-CoV-2 (PASC) Infection.”
Journal of Head Injury Rehabilitation: “Efficacy of Amantadine Hydrochloride in Reducing Chronic Brain Injury, Irritability, and Aggression.”
Central nervous system drugs: “Modafinil: A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.”
Frontiers in neuroscience: “Methylphenidate Treatment of Cognitive Dysfunction in Adults After Mild-to-Moderate Brain Injury: Rationale, Efficacy, and Neuroprotective Mechanisms.”
PM&R: “An Interdisciplinary Collaborative Consensus Guiding Statement on the Evaluation and Treatment of Cognitive Symptoms in Patients with Post-Acute Effects of SARS-CoV-2 (PASC) Infection.”
Annals of Clinical and Editorial Neuroscience: “Persistent neurological symptoms and cognitive impairment in non-hospitalized long-distance Covid-19 patients.”
Alba Miranda Azola, MD, co-director, COVID-19 Postinfection Team, Johns Hopkins University School of Medicine, Baltimore.
US National Library of Medicine: “SARS-CoV-2 Viral Stability Study (PASC) – Long COVID-19 Study.”
PolyBio: “LongCovid Research Consortium.”
Gary H. Gibbons, MD, director of the National Heart, Lung, and Blood Institute.
Discussion about this post